Nmc Health Dividends - NMC

Nmc Health Dividends - NMC

Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Nmc Health Plc NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  -65.00 -2.5% 2,530.00 2,606.00 2,512.00 2,567.00 2,595.00 16:35:04
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Nmc Health NMC Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
07/03/2019FinalGBX18.131/12/201731/12/201813/06/201914/06/201910/07/201918.1
07/03/2018FinalGBX10.631/12/201631/12/201714/06/201815/06/201810/07/201810.6
08/03/2017FinalGBX10.631/12/201531/12/201611/05/201712/05/201702/06/201710.6
14/03/2016FinalGBX6.231/12/201431/12/201519/05/201620/05/201620/06/20166.2
20/05/2015FinalGBX5.431/12/201331/12/201428/05/201529/05/201525/06/20155.4
25/02/2014FinalGBX4.431/12/201231/12/201328/05/201430/05/201403/07/20144.4
26/02/2013FinalGBX4.131/12/201131/12/201229/05/201331/05/201304/07/20134.1

Top Dividend Posts

DateSubject
06/12/2019
09:34
steeplejack: Perhaps.The share buy back programme puts the company in a state of readiness to counter the sort of bear attacks that have afflicted the share price over the last year.I don’t expect NMC to undertake a steady share buy back like those seen in the US in recent years.I see it as more of an ‘emergencyR17; share buy back provision.
14/11/2019
08:46
aquaesulis01: I'll stick my head above the parapet and say that I appreciate research based comments from both bull and bear contributors as it helps to provide a balanced view of both the short and mid/long term company prospects and market sentiment. Yertiz has a short term view that is pessimistic based on trend whilst rabbitfoot has countered with a candlestick pattern view based on a golden cross. At the end of the day it is news that will shift this substantially in one direction or another and on previous history an RNS normally has a positive effect on the share price because NMC have a good story to tell. My previous reference to the value of the health data held by NMC which has not been factored into the target share price by any of the analysts is valid, The CEO CMD presentation slide pack at slide 53 shows the basis for the $51 Billion unrealised benefit attributed to data hTTps://nmc.ae/investor-relations
01/11/2019
17:47
rabbitfoot1: What just happened to Fitbit' shareholders is something to keep in mind: https://finance.yahoo.com/news/dont-forget-about-this-in-googles-21-billion-deal-for-fibit-160507239.html As NMC's share price keeps hitting new lows for no apparent reason (in fact, contrary to reason), NMC is becoming an easier takeover target by the likes of Fosun, and should this happen, it would translate into tremendous value destruction for the current shareholders. Like I said in my previous post, I believe this sharp decline is nothing but manipulation, engineered for some obscure purpose that we should all be weary of.
29/10/2019
09:49
yertiz: Good points well made, steeplejack. No one can forecast share price movement with any accuracy on an hour by hour, day by day basis, but they can see how trends are set, how companies are positioned and what influences decisions made by hedge funds, shorters and the like have on the company's fortunes over a period of time. This particular time for NMC has seen an influx of ramping posts on ADVFN (mostly by non-entities or Bots) trying to influence private investors to buy when most of the markers and signs are to sell. I question that motive and would dearly like to know who is/are actually behind some of those meaningless and posturing posts. The hint of a bad report from one shorting company sent NMC spiralling downwards, though the rumours appear unfounded, but there's no smoke without fire, and that is what is currently holding NMC back. No news is good news, but any vestige of weakness in a seemingly 'good' report tears the co to shreds. I would also like to know how much influence these rampers (bot drivers) believe they have on a BB on ADVFN, to my mind extremely little judging by the number of posters on NMC. I dislike ramping, I abhor shorting but they are all part of investment life and anyone basing their research and investment choice on a BB deserves exactly what they get. Take everything with a large pinch of salt. GLA, but as of this morning, I'm out of NMC completely until sub £20 is reached.
19/9/2019
08:03
steeplejack: https://shorttracker.co.uk/company/GB00B7FC0762/ Yes AQR are looking to slide out the back door.I can’t see that they’re banking a profit on these most recent trades. Analysts at Berenberg raised their target price on healthcare provider NMC Health from £36 to £40 on Wednesday (18 Sept)stating that its bear case was "going into hibernation" following the group's recent first-half results. Berenberg said NMC's interim results brought with them an inflexion point for the group's shares and argued that persistently strong fundamental trends had now come back into market focus, striking a positive chord with investors, while further diminishing the bear case. Strong fundamentals across the board were further supported by NMC announcing an opportunistic share buyback programme of up to $200m, which was intended to capitalise on what Berenberg, and the company, viewed as "a materially undervalued share price". "We increase our price target to £40.00 (from £36.00 previously), reflecting higher revenue expectations, improved cash dynamics and better visibility on the fundamental drivers," said the German bank. Berenberg also expects to see NMC's "impressive" momentum in organic growth for underlying earnings and revenues continue, pointing out that there was "little reason" why it should not sustain this performance in the "years to come". The analysts felt the company was about to enter "a new phase", shifting away from large-scale mergers and acquisition in order to focus on integrating its acquired businesses and maturing operational beds, which they expect to drive margin expansion and support further double-digit top-line growth. "We believe this shift in focus will continue to be appreciated by the market, lowering the risk profile of the business, allowing for improved cash dynamics and enabling the underlying business to accelerate on the back of previous CAPEX investments," said Berenberg. Feedback
27/8/2019
17:19
mohdusman44: The functions that I would like see a great improvement within NMC is its PR and IR team. Both these departments seems not upto the mark during the share price fall. Nmc could have handled and arrested the share price fall aided by shorts and post the Muddywater episode in a much better and effective manner preventing the share price from nosediving. Investors were clueless and in a panic mode. A proper communique on a timely manner plus a good PR would have avoided this situation wherein investors ended burning their fingers.
10/8/2019
14:38
alexka1: Here is the CITI note published 2 days ago... as i said over 20% if short - this is the time to buy, its so crowded as a trade on no news. just ppl getting on a trade without reasons following the few big HFs and recent price slumps. NMC Health (NMC.L) Alert: Stock down >10% on no news, our thoughts... The NMC share price is 10-15% lower in afternoon trading, and we see no company-specific or industry news flow. We struggle to explain the move based on fundamentals but offer thoughts on what might be driving the shares weaker, however unjustified we think the move is: – Yesterday, NMC’s shares fell ~7% on no news flow as well: We believe that some investors might have drawn negative conclusions regarding NMC from a tweet by Muddy Waters Research about a new publication released on 7 August. The stock in this publication turned out to be Burford Capital Ltd (BURF.L, not rated), which today is trading ~50% lower. The knock-on effects of this severe move for Burford could be impacting NMC’s share price (on risk aversion). – The influence of the shorts could be accentuating these moves: >20% of NMC’s float is shorted currently, and a large portion of the short positions are at momentum funds, which could be compounding the price action. With Monday’s positive development of the partial removal of pledged stock by insiders, some active shorts may see time as running out for the forced selling to be triggered related to pledged stock (see NMC Health - Partial pledge removal). Total removal of the pledge would dent the bear case, in our view. Active shorts might be opportunistically aggressive in their selling now. – Lack of buyers to step in is concerning, to us: We are surprised that NMC bulls didn’t see good enough value or have high enough conviction in the stock to apprehend a slide of this quantum. – We like the fundamental story and continue to rate NMC a Buy: Modest EPS cut, big TP cut to reflect new reality. Retain Buy. Citi Research Equities Health Care Facilities CEEMEA │ United Arab Emirates
08/8/2019
12:39
alexka1: Statement re. share price movement FROM NMC WEBSITE- TIME TO BUY ! ! ! NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, notes the recent share price weakness and confirms that it expects to report that, after a good performance in the first half of 2019, trading in the business remains in line with management expectations on all key metrics including revenue, EBITDA, net income, leverage, cash flow conversion and working capital. Full year guidance remains as previously stated. In accordance with accounting requirements, the Company will be reporting its interim results on a post-IFRS 16 basis but intends to also provide pre-IFRS 16 comparators for the purposes of those sell-side research analysts that continue to forecast the Company’s performance on such basis. The Company will be able to comment in further detail and will be reporting its interim results on 22 August 2019 in line with the statement released on Monday 5 August 2019.
08/8/2019
12:38
alexka1: News NMC Health Confirms "Good" Interim Performance Amid Share Price Fall (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of ... Alliance News8 August, 2019 | 12:23PMEmail Form (Alliance News) - Private healthcare operator NMC Health PLC confirmed Thursday the first half of 2019 had delivered a "good" performance with trading in line with expectations. The Gulf-focused firm made the announcement after noting recent "share price weakness" since the start of August. Shares in NMC were 5.5% higher at 2,109.00 pence in London on Thursday, however shares have still shed 15% since the start of August. NMC emphasised performance over the six months ended June was "good" and that trading "remains in line with management expectations" on all key metrics including revenue, earnings before interest, taxes, depreciation & amortisation and leverage. Full year guidance also remains as previously stated.
07/8/2019
20:50
steeplejack: Yes,interesting.There seems to be massive oversupply. However....todayR17;s move as reported by Daily Telegraph: Louis Ashworth, markets reporter 7 AUGUST 2019 • 7:28PM Follow It may not have been the intended target, but NMC Health ended up as collateral damage from Muddy Waters Research’s attack on litigation funder Burford Capital. The Abu Dhabi-based hospital operator’s share ended off just over 11pc, having fallen 6pc on rumours it was the planned target of Muddy Waters’s report. A slide that began in the aftermath of Muddy Waters’s tweet teasing the report, which promised a release at “8am London time”, turned into a full-blown drop, dragging the company’s share price to a two-year low after a year of steady decline. It fell 258p to £20. Burford dropped catastrophically, by as much as 64pc, which resulted in billions of pounds being wiped off its share cap after... The FT carried the following observation: ● NMC Healthcare was the FTSE 100’s sharpest faller, with the United Arab Emirates hospital operator hitting a two-year low. Barclays analysts said they had received “numerous questions” from clients about NMC on Tuesday after Muddy Waters tweeted to tease its research without naming the target. “We believe accounting concerns are misplaced and . . . see an increasing disconnect between fundamentals and valuation at a company with a demonstrable track record in execution,” the broker said of NMC.
Your Recent History
LSE
NMC
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191207 11:03:59